Loading…
Reported covered position: Legislative Aide, Sen. Chuck Schumer
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HERAEUS PRECIOUS METALS via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · 3A
issues relating energy
issues relating to trade
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Source: Senate LDA
| BANCVUE |
| 2 |
| 2014 |
| LEIDOS | 2 | 2014 |
| ADVAMED | 1 | 2014 |
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Master Limited Partnerships Parity Act
Client: REPUBLIC SERVICES · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
PEPFAR Stewardship and Oversight Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
PEPFAR Stewardship and Oversight Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Master Limited Partnerships Parity Act
Client: REPUBLIC SERVICES · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
2014 · third_quarter · 3T
issues relating to solar energy
Trade issues impacting the solar industry
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), SENATE, U.S. Trade Representative (USTR)
PRIVATE EQUITY GROWTH CAPITAL COUNCIL via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to taxation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIVATE EQUITY GROWTH CAPITAL COUNCIL via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · Q4
Issues relating to taxation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERAEUS PRECIOUS METALS via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
issues relating to solar energy
Trade issues impacting the solar industry
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), SENATE, U.S. Trade Representative (USTR)
HERAEUS PRECIOUS METALS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
issues relating to trade
issues relating energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to tax extenders and the taxation of renewable energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
General tax issues Issues related to corporate inversions
BANCVUE via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to the regulation of banking products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to tax reform and corporate inversions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERAEUS PRECIOUS METALS via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to solar energy
Trade issues impacting the solar industry
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), SENATE, U.S. Trade Representative (USTR)
PRIVATE EQUITY GROWTH CAPITAL COUNCIL via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Legislative and regulatory policies affecting private equity. Issues relating to interest deductibility.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues related to tax extenders and the taxation of renewable energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
General tax issues Issues related to corporate inversions
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to the regulation of vapor products
Issues related to the taxation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIVATE EQUITY GROWTH CAPITAL COUNCIL via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Legislative and regulatory policies affecting private equity. Issues relating to interest deductibility.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERAEUS PRECIOUS METALS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating energy
Issues relating to trade
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · 2A
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Implementation of PEPFAR Stewardship and Oversight Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues related to tax extenders and the taxation of renewable energy
Issues relating to renewable energy and waste management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEIDOS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
FY 2015 Labor/HHS Appropriations, funding for vaccine development; FY 2015 Defense Appropriations, Naval Health Research Center funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERAEUS PRECIOUS METALS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
Trade and energy policy as they relate to production and manufacturing in the US and international solar energy industry.
Trade and energy policy as they relate to production and manufacturing in the US and international solar energy industry.
BANCVUE via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
Issues related to the regulation of banking products.
LEIDOS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
Issues relating to existing FY15 DOD and HHS federal budget line items
Issues relating to existing FY15 DOD and HHS federal budget line items
Issues relating to existing FY15 DOD and HHS federal budget line items
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · 1A
Implementation of PEPFAR Stewardship and Oversight Act of 2013
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to tax reform
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIVATE EQUITY GROWTH CAPITAL COUNCIL via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Legislative and regulatory policies affecting private equity. Issues relating to interest deductibility.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Outreach during the month of January 2014 relating to VA oversight of medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIVATE EQUITY GROWTH CAPITAL COUNCIL via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Legislative and regulatory policies affecting private equity. Issues relating to interest deductibility.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE